SQUITIERI, Ferdinando
 Distribuzione geografica
Continente #
NA - Nord America 1.178
EU - Europa 272
AS - Asia 130
SA - Sud America 6
AF - Africa 2
Totale 1.588
Nazione #
US - Stati Uniti d'America 1.171
IT - Italia 98
SG - Singapore 53
SE - Svezia 48
IN - India 44
UA - Ucraina 39
FI - Finlandia 32
DE - Germania 30
CN - Cina 27
GB - Regno Unito 9
CA - Canada 7
AR - Argentina 6
ID - Indonesia 4
IE - Irlanda 3
BE - Belgio 2
BG - Bulgaria 2
NL - Olanda 2
PL - Polonia 2
RU - Federazione Russa 2
TG - Togo 2
CH - Svizzera 1
FR - Francia 1
LK - Sri Lanka 1
RO - Romania 1
TH - Thailandia 1
Totale 1.588
Città #
Fairfield 179
Ashburn 127
Chandler 102
Houston 96
Woodbridge 95
Wilmington 73
Seattle 68
Cambridge 61
Rome 47
Ann Arbor 42
Princeton 34
Singapore 29
Bremen 25
Plano 24
Beijing 21
Millbury 20
Lawrence 19
San Paolo di Civitate 19
Boardman 17
Helsinki 13
Jacksonville 11
San Diego 11
Boston 6
Federal 6
Toronto 6
Andover 5
Falls Church 5
Fremont 5
Norwalk 5
Jakarta 4
Los Angeles 4
San Mateo 4
Catania 3
Dearborn 3
Dublin 3
New York 3
Santa Clara 3
Trento 3
Trieste 3
Brescia 2
Buffalo 2
Des Moines 2
Indiana 2
Lomé 2
London 2
Sofia 2
Waanrode 2
Auburn Hills 1
Broomfield 1
Bühl 1
Centro 1
Chicago 1
Colombo 1
Dayton 1
Falkenstein 1
Guangzhou 1
Hefei 1
Kilburn 1
Lappeenranta 1
Las Vegas 1
Mannheim 1
Mentana 1
Milan 1
Nanjing 1
Nembro 1
Ottawa 1
Phoenix 1
Quanzhou 1
Rieti 1
Seversk 1
Trumbull 1
Warsaw 1
Washington 1
Zurich 1
Totale 1.247
Nome #
Different spectra of genomic deletions within the CCM genes between Italian and American CCM patient cohorts 103
Juvenile Huntington's disease: Does a dosage-effect pathogenic mechanism differ from the classical adult disease? 102
Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage 96
The search for cerebral biomarkers of Huntington's disease: a review of genetic models of age at onset prediction 88
Executive functioning in relapsing-remitting multiple sclerosis patients without cognitive impairment. A task-switching protocol 84
Effects of stimulus-related variables on mental states recognition in huntington's disease 84
Adenosine A2A receptor dysfunction correlates with age at onset anticipation in blood platelets of subjects with Huntington's disease. 81
Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins 79
Early defect of transforming growth factor β1 formation in Huntington's disease. 75
Known drugs identified by structure-based virtual screening are able to bind sigma-1 receptor and increase growth of huntington disease patient-derived cells 74
Early defect of transforming growth factor b-1 formation in Huntington's disease 67
Antidopaminergic Medication is Associated with More Rapidly Progressive Huntington's Disease 67
DNA instability in replicating Huntington's disease lymphoblasts 64
Changes of peripheral TGF-β1 depend on monocytes-derived macrophages in Huntington disease. 64
Glucose transportation in the brain and its impairment in Huntington disease: one more shade of the energetic metabolism failure? 63
Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients 62
Factor analysis of behavioural symptoms in Huntington's disease 59
Genotype-dependent priming to self- and xeno-cannibalism in heterozygous and homozygous lymphoblasts from patients with Huntington's disease 58
Molecular medicine: predicting and preventing Huntington's disease 54
Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease 42
A model to predict the onset age in unaffected Huntington's disease mutation carriers 36
Transforming growth factor beta-1 levels are reduced in brain and serum of presymptomatic Huntington's disease patients 32
Expression and function of metabotropic glutamate receptor subtypes in the R6/2 transgenic mouse model of huntington’s disease. 31
Genotype dependent abnormalities in Huntington's disease lymphoblastoid cell lines 28
“Spazio Huntington”: Tracing the Early Motor, Cognitive and Behavioral Profiles of Kids with Proven Pediatric Huntington Disease and Expanded Mutations > 80 CAG Repeats 18
Structural and metabolic changes in Huntington's disease brain 15
GLUT-1 changes in paediatric Huntington disease brain cortex and fibroblasts: an observational case-control study 14
Cognitive Reserve in Early Manifest Huntington Disease Patients. Leisure Time Is Associated with Lower Cognitive and Functional Impairment 8
Totale 1.648
Categoria #
all - tutte 4.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.440


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020291 0 0 0 22 40 38 43 42 40 33 23 10
2020/2021128 13 15 3 6 2 12 6 28 13 8 13 9
2021/2022272 7 23 26 5 29 9 10 23 19 17 56 48
2022/2023338 66 69 22 52 38 21 12 10 30 3 13 2
2023/2024152 9 16 3 31 9 13 8 14 2 9 10 28
2024/202560 6 6 40 8 0 0 0 0 0 0 0 0
Totale 1.648